ADAM33 and asthma: Other studies have shown that vitamin D inhibits VEGF-induced respiratory smooth muscle cell proliferation by suppressing VEGFR2 and ERK1/2 activation and downregulation of ADAM33, which may be crucial in developing therapies for diseases such as asthma [154].